Counterfeiting of pharmaceuticals and the proliferation of substandard drugs constitute a serious health risk for the world population, including both industrialized and developing countries. It is estimated that five to eight percent of the world’s total pharmaceutical sales are counterfeit or of dubious quality. This application note discusses the identification of counterfeit drugs based on differences in the distribution of ingredients within the product.